A transient ischemic attack — a TIA, or what older language called a “mini-stroke” — is a brief episode of neurologic symptoms caused by a temporary loss of blood flow to part of the brain. The symptoms resolve, but the warning does not: the days right after a TIA carry a real and concentrated risk of a full stroke. The ABCD2 score was created to put a number on that risk in the emergency setting, helping clinicians decide how fast and how aggressively to act. It is a useful tool, but as with any score, the way it is used matters as much as the number it produces.1

What the ABCD2 score measures

ABCD2 combines five clinical factors that, in the original work, predicted very early stroke risk after a TIA. Each is scored and the points are added for a total of 0 to 7.1

  • A — Age: 60 years or older = 1 point.
  • B — Blood pressure: systolic ≥ 140 mm Hg or diastolic ≥ 90 mm Hg at presentation = 1 point.
  • C — Clinical features: unilateral weakness = 2 points; speech disturbance without weakness = 1 point; neither = 0 points.
  • D — Duration: symptoms lasting ≥ 60 minutes = 2 points; 10–59 minutes = 1 point; under 10 minutes = 0 points.
  • D — Diabetes: present = 1 point.

The design is deliberately simple. Everything needed is available at the bedside within minutes — a history, a blood pressure cuff, and a quick neurologic exam — which is part of why the score spread so quickly into emergency departments and clinics.

The original risk groups

In the study that introduced and validated the unified score, higher totals tracked with higher short-term stroke risk. Patients were sorted into three bands, with the headline being the chance of a stroke within 2 days of the TIA.1

  • Low risk (0–3): roughly a 1 percent 2-day stroke risk.
  • Moderate risk (4–5): roughly a 4 percent 2-day stroke risk.
  • High risk (6–7): roughly an 8 percent 2-day stroke risk.

Read plainly, the message is that someone in the highest band had close to a 1-in-12 chance of stroke within just two days — a striking number that helped make the case for treating TIA as the medical urgency it is. The same pattern, with risk climbing as the score rose, held at 7 and 90 days as well.1

Why the score is not the whole story

The honest caveat is that ABCD2 has not performed as cleanly in later studies as it did in the paper that created it. Across independent cohorts, its ability to separate higher-risk from lower-risk patients has been inconsistent, and importantly, a meaningful number of strokes occur in people who score in the “low-risk” range. A reassuring score is not a guarantee of safety.

For that reason, ABCD2 should not be used on its own to decide who gets admitted and who goes home. Some causes of TIA — a tight carotid narrowing, atrial fibrillation, a clot source in the heart — carry high stroke risk regardless of where the score lands. The factors the score leaves out can matter more than the ones it includes. Urgent evaluation, brain imaging, and assessment of the blood vessels (typically with imaging of the neck and head arteries) and the heart rhythm are what actually change outcomes, and they are warranted whether the score is 2 or 7.

Key point

Use ABCD2 to help frame urgency and conversation, not to overrule clinical judgment. A low score never cancels the need for prompt vessel and heart-rhythm evaluation after a suspected TIA.

Where the score still earns its keep

ABCD2 retains a practical role in selecting patients for short-course dual antiplatelet therapy — treatment with two clot-preventing medicines, usually aspirin plus clopidogrel, for a limited window. Two large randomized trials, CHANCE and POINT, tested this combination in people with high-risk TIA or minor ischemic stroke and entered patients using an ABCD2 of 4 or more as part of the high-risk definition. Both found that brief dual therapy reduced early recurrent stroke compared with aspirin alone.23

The benefit is real but not free: POINT showed a higher risk of major bleeding when the combination was carried on too long, which is why the treatment is intended as a short course, not an indefinite one.3 Current secondary-prevention guidance from the American Heart Association and American Stroke Association reflects this, recommending short-term dual antiplatelet therapy for selected high-risk TIA and minor stroke patients started early after the event.4 Here the score is doing what it does best — flagging a higher-risk group — rather than being asked to make a disposition decision on its own.

What to do if you think you have had a TIA

For patients and families, the single most important point is this: TIA symptoms that go away are still an emergency. Sudden weakness or numbness on one side, trouble speaking or understanding speech, a drooping face, vision loss, or a sudden severe loss of balance — even if it lasts only minutes — should prompt a call to emergency services (911 in the US) rather than a wait-and-see approach at home. The risk of a disabling stroke is highest in the first few days, exactly when evaluation and treatment can do the most good. Do not try to calculate your own ABCD2 score and talk yourself out of being seen; the score is a clinician's tool used alongside imaging and tests, not a home self-assessment.